serw-MX  [xml]  
 


    
 DeCS Categories

D02 Organic Chemicals .
D02.455 Hydrocarbons .
D02.455.326 Hydrocarbons, Acyclic .
D02.455.326.146 Alkanes .
D02.455.326.146.100 Alkanesulfonic Acids .
D02.455.326.146.100.050 Alkanesulfonates .
D02.455.326.146.100.050.490 Mesna .
D02.886 Sulfur Compounds .
D02.886.489 Sulfhydryl Compounds .
D02.886.489.590 Mesna .
D02.886.645 Sulfur Acids .
D02.886.645.600 Sulfonic Acids .
D02.886.645.600.055 Alkanesulfonic Acids .
D02.886.645.600.055.050 Alkanesulfonates .
D02.886.645.600.055.050.500 Mesna .
D03 Heterocyclic Compounds .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.759 Purines .
D03.633.100.759.646 Purine Nucleotides .
D03.633.100.759.646.138 Adenine Nucleotides .
D03.633.100.759.646.138.382 Coenzyme A .
D03.633.100.759.646.138.694 NAD 7093 .
D03.633.100.759.646.138.749 NADP 7098 .
D08 Enzymes and Coenzymes .
D08.211 Coenzymes .
D08.211.211 Coenzyme A .
D08.211.589 NAD 7093 .
D08.211.625 NADP 7098 .
D08.811 Enzymes .
D13 Nucleic Acids, Nucleotides, and Nucleosides .
D13.695 Nucleotides .
D13.695.667 Purine Nucleotides .
D13.695.667.138 Adenine Nucleotides .
D13.695.667.138.382 Coenzyme A .
D13.695.667.138.694 NAD 7093 .
D13.695.667.138.749 NADP 7098 .
D13.695.827 Ribonucleotides .
D13.695.827.068 Adenine Nucleotides .
D13.695.827.068.382 Coenzyme A .
D13.695.827.068.694 NAD 7093 .
D13.695.827.068.749 NADP 7098 .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Enzymes and Coenzymes .
Coenzymes and Enzymes .
Enzymes, Coenzymes, and Enzyme Inhibitors .
Biological catalysts and their cofactors. .
1.00
76
 
Coenzymes .
Cofactors, Enzyme .
Enzyme Cofactors .
Small molecules that are required for the catalytic function of ENZYMES. Many VITAMINS are coenzymes. .
0.83
75529
 
/enzymology .
/enzyme activity .
/enzymes .
Used with organisms, except vertebrates, and with organs and tissues. It is also used with diseases for enzymes during the course of the disease, but excludes diagnostic enzyme tests, for which "diagnosis" is used. .
0.75
 
Enzymes .
Biocatalysts .
Biological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified. .
0.75
45425937
 
Coenzyme A .
CoASH .
CoA 2413 .
0.71
24594
 
NAD 7093 .
Dihydronicotinamide Adenine Dinucleotide .
NADH 7093 .
Adenine Dinucleotide, Dihydronicotinamide .
Dinucleotide, Dihydronicotinamide Adenine .
Dinucleotide, Nicotinamide-Adenine .
Nicotinamide Adenine Dinucleotide .
Nucleotide, Diphosphopyridine .
Coenzyme I .
Diphosphopyridine Nucleotide .
DPN 7093 .
Nicotinamide-Adenine Dinucleotide .
Nadide .
A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed) .
0.65
1725237
 
NADP 7098 .
NADPH .
Dinucleotide Phosphate, Nicotinamide-Adenine .
Nicotinamide Adenine Dinucleotide Phosphate .
Nucleotide, Triphosphopyridine .
Phosphate, Nicotinamide-Adenine Dinucleotide .
Coenzyme II .
Nicotinamide-Adenine Dinucleotide Phosphate .
Triphosphopyridine Nucleotide .
Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed) .
0.64
2919040
 
Mesna .
ASTA-D 7093 .
MESNA-cell .
Mesnex .
Mesnum .
Mistabron .
Mistabronco .
Mitexan .
Mucofluid .
Sodium 2-Mercaptoethanesulphonate .
UCB-3983 .
Uromitexan .
Ziken .
2 Mercaptoethanesulfonate .
2-Mercaptoethanesulphonate, Sodium .
ASTA D 7093 .
ASTAD 7093 .
MESNA cell .
UCB 3983 .
UCB3983 .
Coenzyme M .
2-Mercaptoethanesulfonate .
A sulfhydryl compound used to prevent urothelial toxicity by inactivating metabolites from ANTINEOPLASTIC AGENTS, such as IFOSFAMIDE or CYCLOPHOSPHAMIDE. .
0.62
121129